Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-11

Clinical Trial Update: Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating blood pressure and glucose-lowering strategies to prevent vascular disease in high-risk patients with Type 2 diabetes; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The George Institute | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED